H.R.5333: Ensuring Patient Access to Critical Breakthrough Products Act of 2019

About This Bill

Bill Version

Bill Summary

Ensuring Patient Access to Critical Breakthrough Products Act of 2019 This bill provides for Medicare coverage of medical devices that are approved under the Food and Drug Administration (FDA) Breakthrough Devices Program. (Under the program, manufacturers work with the FDA to expedite the review and approval of certain medical devices that provide for more effective treatment or diagnosis of life-threatening or irreversibly debilitating human...

(Source: Library of Congress)

What Lawmakers Are Saying About This Bill

There are 3 statements associated with H.R.5333.

Bill Actions

Date Description
Dec. 9, 2019
Referred to the Subcommittee on Health.
Dec. 6, 2019
Referred to the Committee on Ways and Means, and in addition to the Committee on Energy and Commerce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Dec. 6, 2019

Introduced in the House by Suzan K. DelBene (D-Wash.)

Close Comment Creative Commons Donate Email Facebook Mobile Phone Podcast Print Google News logo Google_NewsInitiative_Lockup_FullColor RSS Search Search Twitter WhatsApp Resolving differences Check Building Arrow right Info circle Oops OOPS Pencil File text Bars Search Close Cogs Filter Compare Revolving Door Info card Activity Member menu Globe Document External link Quote News Calendar No Vote
Current site Current page